A calcineurin- and NFAT-dependent pathway is involved in α-synuclein-induced degeneration of midbrain dopaminergic neurons

Parkinson's disease (PD), the most common degenerative movement disorder, is caused by a preferential loss of midbrain dopaminergic (mDA) neurons. Both α-synuclein (α-syn) missense and multiplication mutations have been linked to PD. However, the underlying intracellular signalling transduction...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Human molecular genetics 2014-12, Vol.23 (24), p.6567-6574
Hauptverfasser: Luo, Jing, Sun, Lixin, Lin, Xian, Liu, Guoxiang, Yu, Jia, Parisiadou, Loukia, Xie, Chengsong, Ding, Jinhui, Cai, Huaibin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 6574
container_issue 24
container_start_page 6567
container_title Human molecular genetics
container_volume 23
creator Luo, Jing
Sun, Lixin
Lin, Xian
Liu, Guoxiang
Yu, Jia
Parisiadou, Loukia
Xie, Chengsong
Ding, Jinhui
Cai, Huaibin
description Parkinson's disease (PD), the most common degenerative movement disorder, is caused by a preferential loss of midbrain dopaminergic (mDA) neurons. Both α-synuclein (α-syn) missense and multiplication mutations have been linked to PD. However, the underlying intracellular signalling transduction pathways of α-syn-mediated mDA neurodegeneration remain elusive. Here, we show that transgenic expression of PD-related human α-syn A53T missense mutation promoted calcineurin (CN) activity and the subsequent nuclear translocation of nuclear factor of activated T cells (NFATs) in mDA neurons. α-syn enhanced the phosphatase activity of CN in both cell-free assays and cell lines transfected with either human wild-type or A53T α-syn. Furthermore, overexpression of α-syn A53T mutation significantly increased the CN-dependent nuclear import of NFATc3 in the mDA neurons of transgenic mice. More importantly, a pharmacological inhibition of CN by cyclosporine A (CsA) ameliorated the α-syn-induced loss of mDA neurons. These findings demonstrate an active involvement of CN- and NFAT-mediated signalling pathway in α-syn-mediated degeneration of mDA neurons in PD.
doi_str_mv 10.1093/hmg/ddu377
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4240205</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1627072229</sourcerecordid><originalsourceid>FETCH-LOGICAL-p299t-b7658cc735fc7f6c475a2ba1eace5321a42d5be525e38810947ea0f7caa321b93</originalsourceid><addsrcrecordid>eNqFUU1P3DAQtapWZYFe-gMqH3sJ-DNOLkgrVNpKCC70HE3sya6rxA5xstWKX8Uf6W_CCFrBidOM5s2892aGkM-cnXBWy9PtsDl1bpHGvCMrrkpWCFbJ92TF6lIVZc3KA3KY0m_GeKmk-UgOhGaa17pakbs1tdBbH3CZfCgoBEevLtY3hcMRg8Mw0xHm7R_YU5-oD7vY79DlhP69L9I-LLbHPOeDW2yuO9xgwAlmHwONHR28ayfI3S6OMGSVaeMtfRSLIR2TDx30CT89xyPy6-LbzfmP4vL6-8_z9WUxirqei9aUurLWSN1Z05VWGQ2iBY5gUUvBQQmnW9RCo6yqfBFlEFhnLEBG21oekbMn3nFpB3Q2LzVB34yTH2DaNxF88xoJftts4q5RQjHBdCb4-kwwxdsF09wMPlnsewgYl9Rww7iqDK_l262lMMwIIR5tfXlp67-ff8-RD7velMc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1627072229</pqid></control><display><type>article</type><title>A calcineurin- and NFAT-dependent pathway is involved in α-synuclein-induced degeneration of midbrain dopaminergic neurons</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Luo, Jing ; Sun, Lixin ; Lin, Xian ; Liu, Guoxiang ; Yu, Jia ; Parisiadou, Loukia ; Xie, Chengsong ; Ding, Jinhui ; Cai, Huaibin</creator><creatorcontrib>Luo, Jing ; Sun, Lixin ; Lin, Xian ; Liu, Guoxiang ; Yu, Jia ; Parisiadou, Loukia ; Xie, Chengsong ; Ding, Jinhui ; Cai, Huaibin</creatorcontrib><description>Parkinson's disease (PD), the most common degenerative movement disorder, is caused by a preferential loss of midbrain dopaminergic (mDA) neurons. Both α-synuclein (α-syn) missense and multiplication mutations have been linked to PD. However, the underlying intracellular signalling transduction pathways of α-syn-mediated mDA neurodegeneration remain elusive. Here, we show that transgenic expression of PD-related human α-syn A53T missense mutation promoted calcineurin (CN) activity and the subsequent nuclear translocation of nuclear factor of activated T cells (NFATs) in mDA neurons. α-syn enhanced the phosphatase activity of CN in both cell-free assays and cell lines transfected with either human wild-type or A53T α-syn. Furthermore, overexpression of α-syn A53T mutation significantly increased the CN-dependent nuclear import of NFATc3 in the mDA neurons of transgenic mice. More importantly, a pharmacological inhibition of CN by cyclosporine A (CsA) ameliorated the α-syn-induced loss of mDA neurons. These findings demonstrate an active involvement of CN- and NFAT-mediated signalling pathway in α-syn-mediated degeneration of mDA neurons in PD.</description><identifier>ISSN: 0964-6906</identifier><identifier>EISSN: 1460-2083</identifier><identifier>DOI: 10.1093/hmg/ddu377</identifier><identifier>PMID: 25051958</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>alpha-Synuclein - genetics ; alpha-Synuclein - metabolism ; Animals ; Apoptosis - drug effects ; Calcineurin - genetics ; Calcineurin - metabolism ; Calcineurin Inhibitors - pharmacology ; Cyclosporine - pharmacology ; Dopaminergic Neurons - drug effects ; Dopaminergic Neurons - metabolism ; Dopaminergic Neurons - pathology ; Gene Expression Regulation ; HEK293 Cells ; Humans ; Mesencephalon - drug effects ; Mesencephalon - metabolism ; Mesencephalon - pathology ; Mice ; Mice, Transgenic ; Mutation ; NFATC Transcription Factors - genetics ; NFATC Transcription Factors - metabolism ; Parkinson Disease - drug therapy ; Parkinson Disease - genetics ; Parkinson Disease - metabolism ; Parkinson Disease - pathology ; Primary Cell Culture ; Signal Transduction</subject><ispartof>Human molecular genetics, 2014-12, Vol.23 (24), p.6567-6574</ispartof><rights>Published by Oxford University Press 2014. This work is written by (a) US Government employee(s) and is in the public domain in the US.</rights><rights>Published by Oxford University Press 2014. This work is written by (a) US Government employee(s) and is in the public domain in the US 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,781,785,886,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25051958$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Luo, Jing</creatorcontrib><creatorcontrib>Sun, Lixin</creatorcontrib><creatorcontrib>Lin, Xian</creatorcontrib><creatorcontrib>Liu, Guoxiang</creatorcontrib><creatorcontrib>Yu, Jia</creatorcontrib><creatorcontrib>Parisiadou, Loukia</creatorcontrib><creatorcontrib>Xie, Chengsong</creatorcontrib><creatorcontrib>Ding, Jinhui</creatorcontrib><creatorcontrib>Cai, Huaibin</creatorcontrib><title>A calcineurin- and NFAT-dependent pathway is involved in α-synuclein-induced degeneration of midbrain dopaminergic neurons</title><title>Human molecular genetics</title><addtitle>Hum Mol Genet</addtitle><description>Parkinson's disease (PD), the most common degenerative movement disorder, is caused by a preferential loss of midbrain dopaminergic (mDA) neurons. Both α-synuclein (α-syn) missense and multiplication mutations have been linked to PD. However, the underlying intracellular signalling transduction pathways of α-syn-mediated mDA neurodegeneration remain elusive. Here, we show that transgenic expression of PD-related human α-syn A53T missense mutation promoted calcineurin (CN) activity and the subsequent nuclear translocation of nuclear factor of activated T cells (NFATs) in mDA neurons. α-syn enhanced the phosphatase activity of CN in both cell-free assays and cell lines transfected with either human wild-type or A53T α-syn. Furthermore, overexpression of α-syn A53T mutation significantly increased the CN-dependent nuclear import of NFATc3 in the mDA neurons of transgenic mice. More importantly, a pharmacological inhibition of CN by cyclosporine A (CsA) ameliorated the α-syn-induced loss of mDA neurons. These findings demonstrate an active involvement of CN- and NFAT-mediated signalling pathway in α-syn-mediated degeneration of mDA neurons in PD.</description><subject>alpha-Synuclein - genetics</subject><subject>alpha-Synuclein - metabolism</subject><subject>Animals</subject><subject>Apoptosis - drug effects</subject><subject>Calcineurin - genetics</subject><subject>Calcineurin - metabolism</subject><subject>Calcineurin Inhibitors - pharmacology</subject><subject>Cyclosporine - pharmacology</subject><subject>Dopaminergic Neurons - drug effects</subject><subject>Dopaminergic Neurons - metabolism</subject><subject>Dopaminergic Neurons - pathology</subject><subject>Gene Expression Regulation</subject><subject>HEK293 Cells</subject><subject>Humans</subject><subject>Mesencephalon - drug effects</subject><subject>Mesencephalon - metabolism</subject><subject>Mesencephalon - pathology</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><subject>Mutation</subject><subject>NFATC Transcription Factors - genetics</subject><subject>NFATC Transcription Factors - metabolism</subject><subject>Parkinson Disease - drug therapy</subject><subject>Parkinson Disease - genetics</subject><subject>Parkinson Disease - metabolism</subject><subject>Parkinson Disease - pathology</subject><subject>Primary Cell Culture</subject><subject>Signal Transduction</subject><issn>0964-6906</issn><issn>1460-2083</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUU1P3DAQtapWZYFe-gMqH3sJ-DNOLkgrVNpKCC70HE3sya6rxA5xstWKX8Uf6W_CCFrBidOM5s2892aGkM-cnXBWy9PtsDl1bpHGvCMrrkpWCFbJ92TF6lIVZc3KA3KY0m_GeKmk-UgOhGaa17pakbs1tdBbH3CZfCgoBEevLtY3hcMRg8Mw0xHm7R_YU5-oD7vY79DlhP69L9I-LLbHPOeDW2yuO9xgwAlmHwONHR28ayfI3S6OMGSVaeMtfRSLIR2TDx30CT89xyPy6-LbzfmP4vL6-8_z9WUxirqei9aUurLWSN1Z05VWGQ2iBY5gUUvBQQmnW9RCo6yqfBFlEFhnLEBG21oekbMn3nFpB3Q2LzVB34yTH2DaNxF88xoJftts4q5RQjHBdCb4-kwwxdsF09wMPlnsewgYl9Rww7iqDK_l262lMMwIIR5tfXlp67-ff8-RD7velMc</recordid><startdate>20141215</startdate><enddate>20141215</enddate><creator>Luo, Jing</creator><creator>Sun, Lixin</creator><creator>Lin, Xian</creator><creator>Liu, Guoxiang</creator><creator>Yu, Jia</creator><creator>Parisiadou, Loukia</creator><creator>Xie, Chengsong</creator><creator>Ding, Jinhui</creator><creator>Cai, Huaibin</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>5PM</scope></search><sort><creationdate>20141215</creationdate><title>A calcineurin- and NFAT-dependent pathway is involved in α-synuclein-induced degeneration of midbrain dopaminergic neurons</title><author>Luo, Jing ; Sun, Lixin ; Lin, Xian ; Liu, Guoxiang ; Yu, Jia ; Parisiadou, Loukia ; Xie, Chengsong ; Ding, Jinhui ; Cai, Huaibin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p299t-b7658cc735fc7f6c475a2ba1eace5321a42d5be525e38810947ea0f7caa321b93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>alpha-Synuclein - genetics</topic><topic>alpha-Synuclein - metabolism</topic><topic>Animals</topic><topic>Apoptosis - drug effects</topic><topic>Calcineurin - genetics</topic><topic>Calcineurin - metabolism</topic><topic>Calcineurin Inhibitors - pharmacology</topic><topic>Cyclosporine - pharmacology</topic><topic>Dopaminergic Neurons - drug effects</topic><topic>Dopaminergic Neurons - metabolism</topic><topic>Dopaminergic Neurons - pathology</topic><topic>Gene Expression Regulation</topic><topic>HEK293 Cells</topic><topic>Humans</topic><topic>Mesencephalon - drug effects</topic><topic>Mesencephalon - metabolism</topic><topic>Mesencephalon - pathology</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><topic>Mutation</topic><topic>NFATC Transcription Factors - genetics</topic><topic>NFATC Transcription Factors - metabolism</topic><topic>Parkinson Disease - drug therapy</topic><topic>Parkinson Disease - genetics</topic><topic>Parkinson Disease - metabolism</topic><topic>Parkinson Disease - pathology</topic><topic>Primary Cell Culture</topic><topic>Signal Transduction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Luo, Jing</creatorcontrib><creatorcontrib>Sun, Lixin</creatorcontrib><creatorcontrib>Lin, Xian</creatorcontrib><creatorcontrib>Liu, Guoxiang</creatorcontrib><creatorcontrib>Yu, Jia</creatorcontrib><creatorcontrib>Parisiadou, Loukia</creatorcontrib><creatorcontrib>Xie, Chengsong</creatorcontrib><creatorcontrib>Ding, Jinhui</creatorcontrib><creatorcontrib>Cai, Huaibin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Human molecular genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Luo, Jing</au><au>Sun, Lixin</au><au>Lin, Xian</au><au>Liu, Guoxiang</au><au>Yu, Jia</au><au>Parisiadou, Loukia</au><au>Xie, Chengsong</au><au>Ding, Jinhui</au><au>Cai, Huaibin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A calcineurin- and NFAT-dependent pathway is involved in α-synuclein-induced degeneration of midbrain dopaminergic neurons</atitle><jtitle>Human molecular genetics</jtitle><addtitle>Hum Mol Genet</addtitle><date>2014-12-15</date><risdate>2014</risdate><volume>23</volume><issue>24</issue><spage>6567</spage><epage>6574</epage><pages>6567-6574</pages><issn>0964-6906</issn><eissn>1460-2083</eissn><abstract>Parkinson's disease (PD), the most common degenerative movement disorder, is caused by a preferential loss of midbrain dopaminergic (mDA) neurons. Both α-synuclein (α-syn) missense and multiplication mutations have been linked to PD. However, the underlying intracellular signalling transduction pathways of α-syn-mediated mDA neurodegeneration remain elusive. Here, we show that transgenic expression of PD-related human α-syn A53T missense mutation promoted calcineurin (CN) activity and the subsequent nuclear translocation of nuclear factor of activated T cells (NFATs) in mDA neurons. α-syn enhanced the phosphatase activity of CN in both cell-free assays and cell lines transfected with either human wild-type or A53T α-syn. Furthermore, overexpression of α-syn A53T mutation significantly increased the CN-dependent nuclear import of NFATc3 in the mDA neurons of transgenic mice. More importantly, a pharmacological inhibition of CN by cyclosporine A (CsA) ameliorated the α-syn-induced loss of mDA neurons. These findings demonstrate an active involvement of CN- and NFAT-mediated signalling pathway in α-syn-mediated degeneration of mDA neurons in PD.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>25051958</pmid><doi>10.1093/hmg/ddu377</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0964-6906
ispartof Human molecular genetics, 2014-12, Vol.23 (24), p.6567-6574
issn 0964-6906
1460-2083
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4240205
source MEDLINE; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects alpha-Synuclein - genetics
alpha-Synuclein - metabolism
Animals
Apoptosis - drug effects
Calcineurin - genetics
Calcineurin - metabolism
Calcineurin Inhibitors - pharmacology
Cyclosporine - pharmacology
Dopaminergic Neurons - drug effects
Dopaminergic Neurons - metabolism
Dopaminergic Neurons - pathology
Gene Expression Regulation
HEK293 Cells
Humans
Mesencephalon - drug effects
Mesencephalon - metabolism
Mesencephalon - pathology
Mice
Mice, Transgenic
Mutation
NFATC Transcription Factors - genetics
NFATC Transcription Factors - metabolism
Parkinson Disease - drug therapy
Parkinson Disease - genetics
Parkinson Disease - metabolism
Parkinson Disease - pathology
Primary Cell Culture
Signal Transduction
title A calcineurin- and NFAT-dependent pathway is involved in α-synuclein-induced degeneration of midbrain dopaminergic neurons
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T10%3A12%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20calcineurin-%20and%20NFAT-dependent%20pathway%20is%20involved%20in%20%CE%B1-synuclein-induced%20degeneration%20of%20midbrain%20dopaminergic%20neurons&rft.jtitle=Human%20molecular%20genetics&rft.au=Luo,%20Jing&rft.date=2014-12-15&rft.volume=23&rft.issue=24&rft.spage=6567&rft.epage=6574&rft.pages=6567-6574&rft.issn=0964-6906&rft.eissn=1460-2083&rft_id=info:doi/10.1093/hmg/ddu377&rft_dat=%3Cproquest_pubme%3E1627072229%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1627072229&rft_id=info:pmid/25051958&rfr_iscdi=true